NCT07505771 2026-04-06A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced CancerImmunome, Inc.Phase EARLY_PHASE1 Recruiting105 enrolled
NCT02537418 2026-03-27Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy RegimensCanadian Cancer Trials GroupPhase 1 Active not recruiting153 enrolled